InvestorsHub Logo

Jesspro

08/11/23 6:01 PM

#17003 RE: moosedogger #17002

Absolutely, Moose! Look at the failed/stopped/canceled drug trials of the more than 8 biopharm companies and the best they could muster is a least effective Belimumab which only works minimally after a short period of use.